Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trial is to evaluate the safety and preliminary efficacy of the autologous 3D osteogenic implant NVD-003 for bone reconstruction for the treatment of recalcitrant lower limb nonunion.


Clinical Trial Description

This is a first in man study conducted as a prospective, single-arm, non-randomized clinical study. A sample of 5 to 10 patients will be enrolled in the study in order to assess the safety of the use of NVD-003 bone graft implantation in patients with recalcitrant lower limb nonunion. The sample size of 5 to 10 patients was considered sufficient to give a preliminary indication on the safety of the ATMP. ;


Study Design


NCT number NCT06335394
Study type Interventional
Source Novadip Biosciences
Contact
Status Active, not recruiting
Phase Phase 1/Phase 2
Start date August 2, 2018
Completion date May 15, 2028